Getting the right dose in cancer chemotherapy – time to stop using surface area?
2002

Getting the right dose in cancer chemotherapy

Editorial Evidence: moderate

Author Information

Author(s): Newell D R

Primary Institution: Cancer Research UK Developmental Therapeutics Programme, Medical School, University of Newcastle

Hypothesis

Is using body surface area the best method for calculating chemotherapy doses?

Conclusion

The reliance on body surface area for determining chemotherapy doses should be reconsidered in favor of more individualized approaches.

Supporting Evidence

  • Using body surface area to calculate drug doses has been a long-standing practice despite its inaccuracies.
  • Variability in drug clearance among patients is not solely related to body surface area.
  • Gurney's paper provides rules for prescribing cytotoxic therapy doses that consider individual patient factors.

Takeaway

Doctors need to be careful when deciding how much chemotherapy to give patients, and just using body size might not be the best way to do it.

Potential Biases

There may be biases in relying on historical data and established practices for dosing.

Limitations

The article discusses the challenges of changing established dosing practices and the need for large trials to confirm safety.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600226

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication